Dillapiole as antileishmanial agent: Discovery, cytotoxic activity and preliminary SAR studies of dillapiole analogues
dc.contributor.author | Parise-Filho R. | |
dc.contributor.author | Pasqualoto K.F.M. | |
dc.contributor.author | Magri F.M.M. | |
dc.contributor.author | Ferreira A.K. | |
dc.contributor.author | Da Silva B.A.V.G. | |
dc.contributor.author | Damiao M.C.F.C.B. | |
dc.contributor.author | Tavares M.T. | |
dc.contributor.author | Azevedo R.A. | |
dc.contributor.author | Auada A.V.V. | |
dc.contributor.author | Polli M.C. | |
dc.contributor.author | Brandt C.A. | |
dc.date.accessioned | 2024-03-13T01:06:54Z | |
dc.date.available | 2024-03-13T01:06:54Z | |
dc.date.issued | 2012 | |
dc.description.abstract | In this paper, the isolation of dillapiole (1) from Piper aduncum was reported as well as the semi-synthesis of two phenylpropanoid derivatives [di-hydrodillapiole (2), isodillapiole (3)], via reduction and isomerization reactions. Also, the compounds' molecular properties (structural, electronic, hydrophobic, and steric) were calculated and investigated to establish some preliminary structure-activity relationships (SAR). Compounds were evaluated for in vitro antileishmanial activity and cytotoxic effects on fibroblast cells. Compound 1 presented inhibitory activity against Leishmania amazonensis (IC 50 = 69.3 μM) and Leishmania brasiliensis (IC50 = 59.4 μM) and induced cytotoxic effects on fibroblast cells mainly in high concentrations. Compounds 2 (IC50 = 99.9 μM for L. amazonensis and IC50 = 90.5 μM for L. braziliensis) and 3 (IC50 = 122.9 μM for L. amazonensis and IC50 = 109.8 μM for L. brasiliensis) were less active than dillapiole (1). Regarding the molecular properties, the conformational arrangement of the side chain, electronic features, and the hydrophilic/hydrophobic balance seem to be relevant for explaining the antileishmanial activity of dillapiole and its analogues. Dillapiole (1) presented relevant effects against Leishmania amazonensis and L. brasiliensis. Additionally, compound 1 reduced fibroblast cell viability, indicating that this compound might have antileishmanial effects on non-phagocytic cells in the latent phase of the disease. SAR studies showed that the conformational arrangement and electronic properties as well as the hydro/lipophilic balance seem to be crucial for antileishmanial activity. Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. | |
dc.description.firstpage | 934 | |
dc.description.issuenumber | 12 | |
dc.description.lastpage | 944 | |
dc.description.volume | 345 | |
dc.identifier.doi | 10.1002/ardp.201200212 | |
dc.identifier.issn | 0365-6233 | |
dc.identifier.uri | https://dspace.mackenzie.br/handle/10899/36742 | |
dc.relation.ispartof | Archiv der Pharmazie | |
dc.rights | Acesso Restrito | |
dc.subject.otherlanguage | Antileishmanial activity | |
dc.subject.otherlanguage | Cytotoxic activity | |
dc.subject.otherlanguage | Dillapiole | |
dc.subject.otherlanguage | Molecular modeling | |
dc.subject.otherlanguage | SAR studies | |
dc.title | Dillapiole as antileishmanial agent: Discovery, cytotoxic activity and preliminary SAR studies of dillapiole analogues | |
dc.type | Artigo | |
local.scopus.citations | 33 | |
local.scopus.eid | 2-s2.0-84870209712 | |
local.scopus.updated | 2024-05-01 | |
local.scopus.url | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84870209712&origin=inward |